54 - Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial
episode
TMO EPM / Hemato H9J
not yet transcribed
Transcript
This episode hasn't been transcribed yet
Upvotes decide what gets transcribed next — 0 so far.
Sign in to upvote
Related
recent transcribed audio
Finance and Budget Committee - Sep 15, 2026
The Art of True Happiness | Dr. Arthur Brooks
The Chris Wolfe Podcast: The Power of Quality Supplements
1208: TM Europe win the '26 Solheim Cup
MORNING TEA: Harry & Meghan's Brutal SNL Roast, Lady Gaga's Baby News & Dakota Johnson's New Man
"I don't think they have enough match winners."| First Thoughts - Brisbane vs Adelaide (14.09.26)